Cargando…
The efficacy and safety of Wulingsan modified formulas for chronic heart failure patients: a systematic review and meta-analysis
BACKGROUND: Chronic heart failure (CHF) is one of the most common cardiovascular diseases, which has caused huge economic burden worldwide. Wulingsan modified formulas have been historically used for CHF in China. However, the efficacy of its treatment for CHF has not been summarized by scholars and...
Autores principales: | Li, Ziyun, Ren, Lang, Gu, Renjun, Zhou, Conghui, Tong, Xu, Hu, Jingqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096312/ https://www.ncbi.nlm.nih.gov/pubmed/35572882 http://dx.doi.org/10.21037/jtd-22-261 |
Ejemplares similares
-
Clinical Outcomes of Wulingsan Subtraction Decoction Treatment of Postoperative Brain Edema and Fever as a Complication of Glioma Neurosurgery
por: Jin, Wei-rong, et al.
Publicado: (2016) -
Evaluation of the Safety and Adverse Effects of Goreisan/Wulingsan, a Traditional Japanese-Chinese Herbal Formulation (Kampo), in a Rat Model: a Toxicological Evaluation
por: Ahmed, Selim, et al.
Publicado: (2014) -
The safety and effectiveness of rehabilitation exercises on COVID-19 patients: A protocol for systematic review and meta-analysis
por: Gu, Renjun, et al.
Publicado: (2020) -
Efficacy and safety of vericiguat in heart failure: a meta-analysis
por: Ma, Jianhua, et al.
Publicado: (2023) -
HJ11 decoction restrains development of myocardial ischemia-reperfusion injury in rats by suppressing ACSL4-mediated ferroptosis
por: Zhang, Fangyuan, et al.
Publicado: (2022)